Advertisement
Covidien
Subscribe to Covidien

The Lead

Covidien Gets FDA 510(k) Clearance for Kangaroo Feeding Tube with IRIS Technology

April 14, 2014 11:20 am | by Covidien | News | Comments

Covidien today announced U.S. Food and Drug Administration 510(k) Clearance for the Kangaroo feeding tube with IRIS Technology. This first-of-its-kind camera-equipped disposable feeding tube is designed to enhance patient safety by providing...

Covidien Implements Voluntary Recall of its Pipeline Embolization Device and Alligator Retrieval Device

April 11, 2014 10:14 am | by Covidien | News | Comments

Covidien plc has announced that it has notified customers of a voluntary recall to address an...

Covidien Announces 510(k) Clearance for the Puritan Bennett 980 Ventilator

February 27, 2014 9:29 am | by Business Wire | News | Comments

Covidien plc, a leading global provider of healthcare products and recognized innovator in...

Covidien Completes Acquisition of Given Imaging

February 27, 2014 7:31 am | by The Associated Press | News | Comments

Covidien plc today announced that it has closed its acquisition of Given Imaging Ltd., providing...

View Sample

FREE Email Newsletter

Covidien Receives Japanese Regulatory Approval for Reinforced Stapling Reload Technology

January 27, 2014 5:11 pm | by The Associated Press | News | Comments

Covidien plc has announced that its Japanese subsidiary, Covidien Japan Inc., has received Shonin approval from the Japanese Ministry of Health, Labor and Welfare for its Endo GIA Reinforced Reload with Tri-Staple technology. This approval...

Covidien Receives FDA Clearance for LigaSure Maryland Jaw

January 23, 2014 11:17 am | by Business Wire | News | Comments

Expanding its industry-leading vessel and tissue sealing portfolio, Covidien received U.S. Food and Drug Administration (FDA) 510(k) clearance for the LigaSure Maryland jaw open/laparoscopic sealer/divider. In addition, Covidien completed...

Covidien to Exit OneShot Renal Denervation Program

January 21, 2014 10:46 am | by Business Wire | News | Comments

Covidien plc has announced it will exit its OneShot Renal Denervation program. This voluntary action is primarily in response to slower than expected development of the renal denervation market. The OneShot system is an over-the-wire...   

Advertisement

Covidien Completes Sale of Confluent Surgical to Integra LifeSciences

January 16, 2014 11:26 am | by Business Wire | News | Comments

Covidien plc today announced that it has completed the sale of its Confluent Surgical product line to Integra LifeSciences Corporation for approximately $235 million in cash. In addition, Covidien may receive up to an additional $30 million...

Integra LifeSciences Completes Acquisition of DuraSeal Product Lines From Covidien

January 15, 2014 2:45 pm | by GlobeNewswire | News | Comments

Integra LifeSciences Holdings Corporation today announced that it has completed the acquisition of DuraSeal product lines from Covidien. Now, together with our DuraGen family of grafts, Integra offers surgeons the largest portfolio of dural repair...

Covidien puts some skin in Irish medtech startup Fire1

January 9, 2014 10:13 am | by Mass Device | News | Comments

Covidien said it participated in the Series A round for stealthy Irish medical device startup Fire1. Dublin-based Fire1 is developing "novel therapeutic devices" to "address certain unmet medical needs," according to a press release. No...

Covidien Announces Definitive Agreement to Acquire Given Imaging

December 8, 2013 2:29 am | by Business Wire | News | Comments

Covidien plc and Given Imaging Ltd. have announced a definitive agreement under which Covidien will acquire all of the outstanding shares of Given Imaging for $30.00 per share in cash, for a total of approximately $860 million, net of cash...

Covidien Launches Vital Sync Virtual Patient Monitoring Platform

November 19, 2013 11:31 am | by Covidien | News | Comments

Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced the launch of the Vital Sync virtual patient monitoring platform. Vital Sync VPMP is a software...

Advertisement

Covidien to Sell Confluent Surgical Product Line to Integra LifeSciences

October 28, 2013 4:05 pm | by Business Wire | News | Comments

Covidien, a leading global provider of healthcare products, announced today that it has entered into a definitive agreement with Integra LifeSciences Corporation to sell its Confluent Surgical product line. The transaction is expected to close by...

Covidien Releases Clinical Data Supporting Treatment and New Approach to Peripheral Arterial Disease

October 14, 2013 4:15 pm | by Business Wire | News | Comments

Covidien, a leading global provider of healthcare products, has released positive final results from its DURABILITY II study and promising preliminary data from its DEFINITIVE AR trial at the Vascular Interventional Advances (VIVA) 2013 conference...

Covidien Launches New Capnography Monitoring Solution

October 11, 2013 12:27 pm | by Business Wire | News | Comments

Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today launched the Capnostream 20p bedside monitor. The new capnography solution, with Covidien’s Microstream technology...

Covidien’s Laryngoscope Combines Direct and Video Laryngoscopy

October 11, 2013 11:49 am | by Covidien | News | Comments

Covidien will present several advanced healthcare solutions for addressing enhanced patient care and safety at Anesthesiology 2013, the American Society of Anesthesiologists (ASA) annual meeting. At the event, held October 12-16 in San Francisco...

Ivera lobs another lawsuit at Covidien

September 24, 2013 2:59 pm | by Mass Device | News | Comments

California medical device maker Ivera Medical announced a 2nd lawsuit against Covidien, this time in a district court in Southern California, claiming infringement of patents for disinfecting caps for medical devices. The new lawsuit alleged infringement of a 4th patent...

Advertisement

Layoffs ahead for Covidien

September 19, 2013 10:06 am | by Mass Device | News | Comments

Covidien said its board of directors authorized a restructuring plan aimed at saving up to $300 million a year by fiscal 2018, with manufacturing and distribution operations slated to be closed. Covidien did not reveal how many layoffs would be involved.

Covidien sued for patent infringement of valve disinfection systems

September 18, 2013 12:19 pm | by Mass Device | News | Comments

Medical device giant Covidien is at the center of a new infringement lawsuit accusing the company of violating a trio of Ivera Medical patents for technologies used to clean and disinfect certain valves and IV connectors. The devices in question are small caps that fit over the ends of needle-less IV connectors...

South Korea is a "key market" in Covidien's global strategy

August 27, 2013 1:36 pm | by Mass Device | News | Comments

Massachusetts medical device maker Covidien is opening the doors on a new Center of Innovation in South Korea, a country that the company calls "a key market in our global strategy." Covidien plans to spend $21 million over the course of 3 years to support the center...

Covidien Opens US$21 Million Research & Development and Training & Education Center in South Korea

August 27, 2013 7:00 am | by Business Wire | News | Comments

Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the opening of the Covidien Center of Innovation Korea (CCI Korea), its first research & development (R&D) and training & education center in Korea. With a total investment of US$21 million over a three year period, CCI Korea is a high-tech medical training center focused on raising awareness of various disease states...

Covidien recalls flush syringes

August 20, 2013 1:59 pm | by Mass Device | News | Comments

Covidien recalled some lots of its Monoject syringes after discovering a sterilization mishap and labeling problem. The issues affected 14 lots in shipments that went out to customers in the U.S. and Bermuda, the Mansfield, Mass.-based medical products giant said.

CAS Medical wins a legal round against Covidien's Nellcor

August 12, 2013 11:31 am | by Mass Device | News | Comments

CAS Medical (NSDQ:CASM) won a round in a legal battle with Covidien's (NYSE:COV) Nellcor patient monitoring subsidiary over technology used to measure oxygen levels in the brain, after a federal judge in Michigan tossed a breach-of-contract claim against CasMed.

Covidien launches 2 trials to support its Stellarex drug-device combo

July 17, 2013 9:58 am | by Mass Device | News | Comments

Covidien kicked off 2 new clinical trials this week to support a global evaluation of its Stellarex drug-coated angioplasty balloon. The Massachusetts-based company started enrolling patients with peripheral arterial disease in the Pivotal and PK arms of its larger ILLUMENATE clinical trials examining the safety and effectiveness of Covidien's Stellarex devices.

Covidien and Nuvon Release New Interface Supporting Electronic Charting

July 9, 2013 2:00 pm | by Covidien | News | Comments

Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, has released a new interface making the INVOS™ cerebral oximetry system compatible with the Nuvon System. The technology allows hospitals to integrate patient data with Electronic Medical Record (EMR) systems.

U.S. Disallows $2.86B in Deductions Taken by Tyco

July 8, 2013 4:23 pm | by The Associated Press | News | Comments

The U.S. tax agency has informed Tyco International Ltd. that it has disallowed roughly $2.86 billion in interest and deductions recognized by the company in its tax returns for the 1997-2000 tax years, according to a filing with the Securities and Exchange Commission.

Covidien could be on the hook for nearly $450M in back taxes

July 2, 2013 12:23 pm | by Mass Device | News | Comments

Covidien could wind up stuck with its share of a $1.07 billion tax bill, after the IRS told its former corporate parent, Tyco International, that tax deductions it took from 1997 to 2000 will be disallowed, according to a regulatory filing.  

Covidien Completes Separation of Pharmaceuticals Business

July 1, 2013 7:00 am | by Business Wire | News | Comments

Covidien, a leading global provider of healthcare products, today announced it has completed the separation of its Pharmaceuticals business, which is now held by Mallinckrodt plc, a new independent company. Mallinckrodt will begin “regular way” trading on the New York Stock Exchange today under the symbol "MNK."

Covidien Announces Publication of Final Results of Pipeline Embolization Device Pivotal Study

June 21, 2013 7:00 am | by Business Wire | News | Comments

Covidien (NYSE:COV), a leading global provider of healthcare products, today announced that the final results of the PUFs (Pipeline for Uncoilable or Failed Aneurysms) clinical study of its Pipeline™ embolization device have been published in the June issue of Radiology. Radiology is the official peer-reviewed medical journal of the Radiological Society of North America.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading